HBM Genomics

HBM Genomics invests in world-class entrepreneurs building life sciences companies from its base in Palo Alto, California. The firm primarily focuses on early-stage biotech opportunities, providing capital and strategic guidance to emerging ventures. Saeid Akhtari, the founder and managing director, leverages his extensive 25+ years of biotech experience to advise and support portfolio firms, having previously founded companies like NextBio (acquired by Illumina in 2013) and Silicon Genetics (acquired by Agilent in 2004). HBM Genomics' portfolio includes notable companies such as Genalyte, Clear Labs, Convergent Genomics, Encoded Therapeutics, and Haystack Biosciences, reflecting its commitment to innovative life sciences solutions. The firm's investment capital is primarily sourced from Saeid Akhtari's personal or managed funds, enabling flexible and targeted investments. HBM Genomics was founded by Saeid Akhtari, with the specific founding year not publicly disclosed.